We aimed to compare seroprevalence of anti-myelin oligodendrocyte glycoprotein (MOG) and anti-aquaporin-4 (AQP4) antibodies in Korean adults with inflammatory demyelinating diseases (IDDs) of the central nervous system (CNS), based on a multicenter nationwide database. Sera were analyzed using a live cell–based assay for MOG and AQP4 antibodies. Of 586 Korean adults with IDDs of the CNS, 36 (6.1%) and 185 (31.6%) tested positive for MOG and AQP4 antibodies, respectively. No participant showed double positivity. Seroprevalence of MOG antibodies was about five times lower than that of AQP4 antibodies in a large cohort of Korean adults with IDDs of the CNS.
SatoDKCallegaroDLana-PeixotoMA, et al. Distinction between MOG antibody-positive and AQP4 antibody-positive NMO spectrum disorders. Neurology2014; 82: 474–481.
3.
KimYHyunJWWoodhallMR, et al. Refining cell-based assay to detect MOG-IgG in patients with central nervous system inflammatory diseases. Mult Scler Relat Disord2020; 40: 101939.
4.
KimYKimGKongBS, et al. Large-scale in-house cell-based assay for evaluating the serostatus in patients with neuromyelitis optica spectrum disorder based on new diagnostic criteria. J Clin Neurol2017; 13(2): 175–180.
5.
KunchokAChenJJMcKeonA, et al. Coexistence of myelin oligodendrocyte glycoprotein and aquaporin-4 antibodies in adult and pediatric patients. JAMA Neurol2019; 77: 257–259.
6.
KimSMWoodhallMRKimJS, et al. Antibodies to MOG in adults with inflammatory demyelinating disease of the CNS. Neurol Neuroimmunol Neuroinflamm2015; 2(6): e163.
7.
SirithoSSatoDKKanekoK, et al. The clinical spectrum associated with myelin oligodendrocyte glycoprotein antibodies (MOG-Ab) in Thai patients. Mult Scler2016; 22: 964–968.
8.
KimJEParkSHHanK, et al. Prevalence and incidence of neuromyelitis optica spectrum disorder and multiple sclerosis in Korea. Mult Scler2020; 26(14): 1837–1844.
9.
HyunJWWoodhallMRKimSH, et al. Longitudinal analysis of myelin oligodendrocyte glycoprotein antibodies in CNS inflammatory diseases. J Neurol Neurosurg Psychiatry2017; 88(10): 811–817.
